Breast Cancer Symposium Evaluation - September 23, 2017

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Create an understanding of the rationale for this new treatment modality.	Create an understanding of the rationale for this new treatment modality. - 5	Create an understanding of the rationale for this new treatment modality. - 4	Create an understanding of the rationale for this new treatment modality. - 3	Create an understanding of the rationale for this new treatment modality. - 2	Create an understanding of the rationale for this new treatment modality. - 1	Create an understanding of the rationale for this new treatment modality. - 0
List physical and dosimetric advantages.	List physical and dosimetric advantages. - 5	List physical and dosimetric advantages. - 4	List physical and dosimetric advantages. - 3	List physical and dosimetric advantages. - 2	List physical and dosimetric advantages. - 1	List physical and dosimetric advantages. - 0
Differentiate integrative versus alternative use of healing modalities.	Differentiate integrative versus alternative use of healing modalities. - 5	Differentiate integrative versus alternative use of healing modalities. - 4	Differentiate integrative versus alternative use of healing modalities. - 3	Differentiate integrative versus alternative use of healing modalities. - 2	Differentiate integrative versus alternative use of healing modalities. - 1	Differentiate integrative versus alternative use of healing modalities. - 0
Discuss the differences between traditional versus evidence-based acupuncture.	Discuss the differences between traditional versus evidence-based acupuncture. - 5	Discuss the differences between traditional versus evidence-based acupuncture. - 4	Discuss the differences between traditional versus evidence-based acupuncture. - 3	Discuss the differences between traditional versus evidence-based acupuncture. - 2	Discuss the differences between traditional versus evidence-based acupuncture. - 1	Discuss the differences between traditional versus evidence-based acupuncture. - 0
Identify the concerns of undocumented and unsupervised use of supplements.	Identify the concerns of undocumented and unsupervised use of supplements. - 5	Identify the concerns of undocumented and unsupervised use of supplements. - 4	Identify the concerns of undocumented and unsupervised use of supplements. - 3	Identify the concerns of undocumented and unsupervised use of supplements. - 2	Identify the concerns of undocumented and unsupervised use of supplements. - 1	Identify the concerns of undocumented and unsupervised use of supplements. - 0
Discuss controversies in current breast cancer treatment options.	Discuss controversies in current breast cancer treatment options. - 5	Discuss controversies in current breast cancer treatment options. - 4	Discuss controversies in current breast cancer treatment options. - 3	Discuss controversies in current breast cancer treatment options. - 2	Discuss controversies in current breast cancer treatment options. - 1	Discuss controversies in current breast cancer treatment options. - 0
Assess future challenges in the management of breast cancer.	Assess future challenges in the management of breast cancer. - 5	Assess future challenges in the management of breast cancer. - 4	Assess future challenges in the management of breast cancer. - 3	Assess future challenges in the management of breast cancer. - 2	Assess future challenges in the management of breast cancer. - 1	Assess future challenges in the management of breast cancer. - 0
Explain the biological rationale behind dose-dense chemotherapy.	Explain the biological rationale behind dose-dense chemotherapy. - 5	Explain the biological rationale behind dose-dense chemotherapy. - 4	Explain the biological rationale behind dose-dense chemotherapy. - 3	Explain the biological rationale behind dose-dense chemotherapy. - 2	Explain the biological rationale behind dose-dense chemotherapy. - 1	Explain the biological rationale behind dose-dense chemotherapy. - 0
Summarize cumulative data in support of dose-dense chemotherapy.	Summarize cumulative data in support of dose-dense chemotherapy. - 5	Summarize cumulative data in support of dose-dense chemotherapy. - 4	Summarize cumulative data in support of dose-dense chemotherapy. - 3	Summarize cumulative data in support of dose-dense chemotherapy. - 2	Summarize cumulative data in support of dose-dense chemotherapy. - 1	Summarize cumulative data in support of dose-dense chemotherapy. - 0
Recognize the implications of the concept in the era of precision medicine.	Recognize the implications of the concept in the era of precision medicine. - 5	Recognize the implications of the concept in the era of precision medicine. - 4	Recognize the implications of the concept in the era of precision medicine. - 3	Recognize the implications of the concept in the era of precision medicine. - 2	Recognize the implications of the concept in the era of precision medicine. - 1	Recognize the implications of the concept in the era of precision medicine. - 0
Explain the criteria for genetic testing availability.	Explain the criteria for genetic testing availability. - 5	Explain the criteria for genetic testing availability. - 4	Explain the criteria for genetic testing availability. - 3	Explain the criteria for genetic testing availability. - 2	Explain the criteria for genetic testing availability. - 1	Explain the criteria for genetic testing availability. - 0
Discuss single-gene versus multi-gene approaches.	Discuss single-gene versus multi-gene approaches. - 5	Discuss single-gene versus multi-gene approaches. - 4	Discuss single-gene versus multi-gene approaches. - 3	Discuss single-gene versus multi-gene approaches. - 2	Discuss single-gene versus multi-gene approaches. - 1	Discuss single-gene versus multi-gene approaches. - 0
Assess new information regarding new genes, including screening recommendations when available.	Assess new information regarding new genes, including screening recommendations when available. - 5	Assess new information regarding new genes, including screening recommendations when available. - 4	Assess new information regarding new genes, including screening recommendations when available. - 3	Assess new information regarding new genes, including screening recommendations when available. - 2	Assess new information regarding new genes, including screening recommendations when available. - 1	Assess new information regarding new genes, including screening recommendations when available. - 0
Define and explain the meaning of variant uncertain significance (VUS).	Define and explain the meaning of variant uncertain significance (VUS). - 5	Define and explain the meaning of variant uncertain significance (VUS). - 4	Define and explain the meaning of variant uncertain significance (VUS). - 3	Define and explain the meaning of variant uncertain significance (VUS). - 2	Define and explain the meaning of variant uncertain significance (VUS). - 1	Define and explain the meaning of variant uncertain significance (VUS). - 0
Explain current guidelines and recommendations regarding screening mammograms.	Explain current guidelines and recommendations regarding screening mammograms. - 5	Explain current guidelines and recommendations regarding screening mammograms. - 4	Explain current guidelines and recommendations regarding screening mammograms. - 3	Explain current guidelines and recommendations regarding screening mammograms. - 2	Explain current guidelines and recommendations regarding screening mammograms. - 1	Explain current guidelines and recommendations regarding screening mammograms. - 0
Discuss the benefits of screening mammograms focusing on women starting at age 40.	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 5	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 4	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 3	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 2	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 1	Discuss the benefits of screening mammograms focusing on women starting at age 40. - 0
Identify the role of additional imaging in screening for breast cancer.	Identify the role of additional imaging in screening for breast cancer. - 5	Identify the role of additional imaging in screening for breast cancer. - 4	Identify the role of additional imaging in screening for breast cancer. - 3	Identify the role of additional imaging in screening for breast cancer. - 2	Identify the role of additional imaging in screening for breast cancer. - 1	Identify the role of additional imaging in screening for breast cancer. - 0
Implement an algorithm for the screening of high-risk patients.	Implement an algorithm for the screening of high-risk patients. - 5	Implement an algorithm for the screening of high-risk patients. - 4	Implement an algorithm for the screening of high-risk patients. - 3	Implement an algorithm for the screening of high-risk patients. - 2	Implement an algorithm for the screening of high-risk patients. - 1	Implement an algorithm for the screening of high-risk patients. - 0
Assess the ongoing revolution in communication and how it influences thought patterns.	Assess the ongoing revolution in communication and how it influences thought patterns. - 5	Assess the ongoing revolution in communication and how it influences thought patterns. - 4	Assess the ongoing revolution in communication and how it influences thought patterns. - 3	Assess the ongoing revolution in communication and how it influences thought patterns. - 2	Assess the ongoing revolution in communication and how it influences thought patterns. - 1	Assess the ongoing revolution in communication and how it influences thought patterns. - 0
Explain the effects of computer use during doctor-patient interactions.	Explain the effects of computer use during doctor-patient interactions. - 5	Explain the effects of computer use during doctor-patient interactions. - 4	Explain the effects of computer use during doctor-patient interactions. - 3	Explain the effects of computer use during doctor-patient interactions. - 2	Explain the effects of computer use during doctor-patient interactions. - 1	Explain the effects of computer use during doctor-patient interactions. - 0
Identify the complex implications of changed communications in the precision medicine era.	Identify the complex implications of changed communications in the precision medicine era. - 5	Identify the complex implications of changed communications in the precision medicine era. - 4	Identify the complex implications of changed communications in the precision medicine era. - 3	Identify the complex implications of changed communications in the precision medicine era. - 2	Identify the complex implications of changed communications in the precision medicine era. - 1	Identify the complex implications of changed communications in the precision medicine era. - 0
Implement the use of adjuvant fat grating.	Implement the use of adjuvant fat grating. - 5	Implement the use of adjuvant fat grating. - 4	Implement the use of adjuvant fat grating. - 3	Implement the use of adjuvant fat grating. - 2	Implement the use of adjuvant fat grating. - 1	Implement the use of adjuvant fat grating. - 0
Identify nipple-sparing procedures in appropriate candidates.	Identify nipple-sparing procedures in appropriate candidates. - 5	Identify nipple-sparing procedures in appropriate candidates. - 4	Identify nipple-sparing procedures in appropriate candidates. - 3	Identify nipple-sparing procedures in appropriate candidates. - 2	Identify nipple-sparing procedures in appropriate candidates. - 1	Identify nipple-sparing procedures in appropriate candidates. - 0
Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions.	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 5	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 4	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 3	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 2	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 1	Apply the use of stacked flaps and expanded flaps for low-BMI patients wanting autologous reconstructions. - 0
Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI).	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 5	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 4	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 3	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 2	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 1	Discuss the prevalence, phenomenology, risk factors and course of cancer-related cognitive impairment (CRCI). - 0
Implement management and prevention strategies for CRCI.	Implement management and prevention strategies for CRCI. - 5	Implement management and prevention strategies for CRCI. - 4	Implement management and prevention strategies for CRCI. - 3	Implement management and prevention strategies for CRCI. - 2	Implement management and prevention strategies for CRCI. - 1	Implement management and prevention strategies for CRCI. - 0
Explain the pathophysiology of CRCI.	Explain the pathophysiology of CRCI. - 5	Explain the pathophysiology of CRCI. - 4	Explain the pathophysiology of CRCI. - 3	Explain the pathophysiology of CRCI. - 2	Explain the pathophysiology of CRCI. - 1	Explain the pathophysiology of CRCI. - 0

How effective were the following speakers in meeting their learning objectives? *

Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective Speakers are listed according to the lecture schedule.

	5	4	3	2	1
Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D.	Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D. - 5	Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D. - 4	Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D. - 3	Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D. - 2	Applications of Proton Therapy in Breast Cancer - Marcio Fagundes, M.D. - 1
Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH	Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH - 5	Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH - 4	Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH - 3	Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH - 2	Integrative Oncology: Paradigm Shift - Yoon Hang “John” Kim, M.D., MPH - 1
Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D.	Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D. - 5	Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D. - 4	Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D. - 3	Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D. - 2	Breast Cancer 2017: Hot Topics, Controversies and Challenges - Jane E. Mendez, M.D. - 1
Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D.	Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D. - 5	Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D. - 4	Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D. - 3	Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D. - 2	Dose-Dense Chemotherapy: Does It Work and Why? - Larry Norton, M.D. - 1
Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D.	Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D. - 5	Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D. - 4	Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D. - 3	Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D. - 2	Hereditary Breast Cancer Syndrome - Arelis E. Martir-Negron, M.D. - 1
Breast Imaging Update - Katharine Lampen-Sachar, M.D.	Breast Imaging Update - Katharine Lampen-Sachar, M.D. - 5	Breast Imaging Update - Katharine Lampen-Sachar, M.D. - 4	Breast Imaging Update - Katharine Lampen-Sachar, M.D. - 3	Breast Imaging Update - Katharine Lampen-Sachar, M.D. - 2	Breast Imaging Update - Katharine Lampen-Sachar, M.D. - 1
The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D.	The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D. - 5	The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D. - 4	The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D. - 3	The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D. - 2	The Doctor-Patient Relationship in an Era of Precision Medicine - Larry Norton, M.D. - 1
Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D.	Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D. - 5	Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D. - 4	Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D. - 3	Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D. - 2	Advances in Autologous and Implant-Based Breast Reconstruction - Miguel A. Medina III, M.D. - 1
Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D.	Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D. - 5	Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D. - 4	Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D. - 3	Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D. - 2	Diagnosis, Pathophysiology and Management of Cancer-Related Cognitive Impairment - Beatriz B. Currier, M.D. - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

Is this your first time attending this symposium? *

Yes

No

How did you hear about us? *

Would you attend this symposium again next year? *

Yes

No

If you checked "No,” please tell us why: *

Would you recommend this symposium to a colleague? *

If you checked "No,” please explain why you would not recommend this course: *

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so.

Suggested topics and/or speakers you would like for future symposiums.

Comments

Name

You are here

Breast Cancer Symposium Evaluation - September 23, 2017